
Nutra Pharma Unveils Updated Websites
Nutra Pharma Corporation is inviting visitors to explore its new websites at www.nutrapharma.com and www.nyloxin.com. The new websites have been designed to provide the ultimate user-friendly experience with improved navigation and functionality throughout. January 25, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-the-counter (

Nutra Pharma Partners with EuroAmerican IP to Distribute Nyloxin for Sale to Government Agencies
Nutra Pharma is partnering with EuroAmerican IP, LLC to distribute their Over-the-Counter (OTC) pain reliever, Nyloxin® Topical Gel, through EuroAmerican IP's existing Federal Supply Schedule #V797D-40251 January 18, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation(OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-AwayTM in the over-the-counter (OTC) pain management market, announced today that they have partnered with EuroAmerican IP, LLC to distr